Head to head
Prudential vs Manulife Financial
Side-by-side on the measures that matter, with a plain-English read. Full detail: PUK · MFC
PUK
Prudential
24.19-2.38%
1-year price shape — -10% over the period
Quant Rating D · 28/100
vs
MFC
Manulife Financial
40.89-2.34%
1-year price shape — +25% over the period
Quant Rating C · 71/100
1-year performance, rebased to 100
Prudential edges it on the scoreable measures. Prudential trades cheapest on trailing earnings; Prudential earns the most per share.
| PUK | MFC | |
|---|---|---|
| Snapshot | ||
| Sector | Insurance - Life | -- |
| Last price | 24.19 | 40.89 |
| Change today | -2.38% | -2.34% |
| 1-year return | -9.6% | +25.2% |
| Market cap | $29.79B | $67.55B |
| 52-week range | 23.31 – 33.36 | 31.75 – 45.82 |
| Valuation | ||
| P/E (TTM) | 8.51 | 16.80 |
| P/E percentile, own 5-yr range | 21st | 100th |
| P/B | 1.50 | 2.04 |
| Dividend yield | 2.20% | 3.26% |
| Profitability & growth | ||
| EPS (TTM) | 3.07 | 2.14 |
| Net profit (TTM) | $3.78B | $3.54B |
| Revenue (TTM) | $64.42B | $52.13B |
| Provider revenue period date | 2007-12-30 | 2026-09-29 |
| Revenue growth (YoY) | -35.8% | -30.9% |
| Gross margin | -- | -- |
| Operating margin | -- | -- |
| Net margin | 12.3% | 4.8% |
| Free cash flow (TTM) | -- | $30.95B |
| Provider cash-flow period date | -- | 2026-06-29 |
| Ownership & sentiment | ||
| Institutional ownership | 83.9% | 58.5% |
| Insider activity (12mo) | 0 buy / 0 sell | 10 buy / 0 sell |
| Short interest (% of float) | 0.1% | 0.8% |
| Analyst consensus | 100% buy (2) | 60% buy / 40% hold (5) |
| Analyst price target | $39 (+62%) | $47 (+15%) |
| StockVane view | ||
| StockVane Quant Rating | D (28) | C (71) |
| Company | ||
| Employees | 15,150 | 27,000 |
| Founded | 1978 | 1887 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.